MARKET

ALZN

ALZN

Alzamend Neuro Inc
NASDAQ
1.980
+0.110
+5.88%
After Hours: 2.060 +0.08 +4.04% 19:37 02/06 EST
OPEN
1.870
PREV CLOSE
1.870
HIGH
2.070
LOW
1.870
VOLUME
72.28K
TURNOVER
--
52 WEEK HIGH
10.71
52 WEEK LOW
1.690
MARKET CAP
7.53M
P/E (TTM)
-0.3470
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALZN last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at ALZN last week (0119-0123)?
Weekly Report · 01/26 09:59
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 01/21 12:05
Weekly Report: what happened at ALZN last week (0112-0116)?
Weekly Report · 01/19 10:03
Weekly Report: what happened at ALZN last week (0105-0109)?
Weekly Report · 01/12 10:02
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 01/09 21:05
Weekly Report: what happened at ALZN last week (1229-0102)?
Weekly Report · 01/05 09:58
Director Milton C. Ault III Reports Sale of Alzamend Neuro Inc. Common Shares
Reuters · 12/30/2025 22:54
More
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.

Webull offers Alzamend Neuro Inc stock information, including NASDAQ: ALZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALZN stock methods without spending real money on the virtual paper trading platform.